Recombinant bone morphogenic protein-2 in orthopaedic surgery: a review

被引:46
作者
Valdes, Mauricio A. [3 ]
Thakur, Nikhil A. [3 ]
Namdari, Surena [2 ]
Ciombor, Deborah M. [3 ]
Palumbo, Mark [1 ,3 ]
机构
[1] Univ Orthoped, Providence, RI 02905 USA
[2] Univ Penn, Dept Orthopaed, Philadelphia, PA 19104 USA
[3] Brown Univ, Rhode Isl Hosp, Dept Orthopaed, Warren Alpert Med Sch, Providence, RI 02903 USA
关键词
Bone morphogenic protein; Spine fusion; Bone healing; Growth factors; Open fractures; LUMBAR INTERBODY FUSION; OPEN TIBIAL FRACTURES; PROTEIN-2/COMPRESSION RESISTANT MATRIX; OSTEOINDUCTIVE GROWTH-FACTOR; SEGMENTAL FEMORAL DEFECTS; SPINAL-FUSION; CLINICAL-EVALUATION; AUTOGRAFT BONE; BASIC SCIENCE; RHBMP-2;
D O I
10.1007/s00402-009-0850-8
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
100224 [整形外科学];
摘要
Bone morphogenic proteins (BMPs) are pleiotropic regulators of bone volume, skeletal organogenesis and bone regeneration after a fracture. They function as signaling agents to affect cellular events like proliferation, differentiation and extracellular matrix synthesis. Clinically utilized rhBMP-2 combines rhBMP-2 with an osteoconductive carrier to induce bone growth and acts as a bone graft substitute. rhBMP-2, initially released in 2002, has been used primarily in spinal fusions in the lumbar and cervical regions. Recently, the application of rhBMP-2 has extended into the orthopedic trauma setting with increased application in open tibia fractures. This review outlines the history of development, molecular characteristics, toxicity and clinical applications.
引用
收藏
页码:1651 / 1657
页数:7
相关论文
共 58 条
[1]
Economic considerations for the use of recombinant human bone morphogenetic protein-2 in open tibial fractures in Europe: The German model [J].
Alt, V. ;
Heissel, A. .
CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 :S19-S22
[2]
Extracellular regulation of BMP signaling in vertebrates: A cocktail of modulators [J].
Balemans, W ;
Van Hul, W .
DEVELOPMENTAL BIOLOGY, 2002, 250 (02) :231-250
[3]
A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR™ allograft ring and the ATLANTIS™ anterior cervical plate [J].
Baskin, DS ;
Ryan, P ;
Sonntag, V ;
Westmark, R ;
Widmayer, MA .
SPINE, 2003, 28 (12) :1219-1224
[4]
Predictors of reoperation following operative management of fractures of the tibial shaft [J].
Bhandari, M ;
Tornetta, P ;
Sprague, S ;
Najibi, S ;
Petrisor, T ;
Griffith, L ;
Guyatt, GH .
JOURNAL OF ORTHOPAEDIC TRAUMA, 2003, 17 (05) :353-361
[5]
Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate [J].
Boden, SD ;
Martin, GJ ;
Morone, MA ;
Ugbo, JL ;
Moskovitz, PA .
SPINE, 1999, 24 (12) :1179-1185
[6]
The use of an osteoinductive growth factor for lumbar spinal fusion .1. Biology of spinal fusion [J].
Boden, SD ;
Schimandle, JH ;
Hutton, WC ;
Chen, MI .
SPINE, 1995, 20 (24) :2626-2632
[7]
The use of an osteoinductive growth factor for lumbar spinal fusion .2. Study of dose, carrier, and species [J].
Boden, SD ;
Schimandle, JH ;
Hutton, WC .
SPINE, 1995, 20 (24) :2633-2644
[8]
Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device [J].
Burkus, JK ;
Heim, TE ;
Gornet, MF ;
Zdeblick, TA .
JOURNAL OF SPINAL DISORDERS & TECHNIQUES, 2003, 16 (02) :113-122
[9]
Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2 [J].
Burkus, JK ;
Dorchak, JD ;
Sanders, DL .
SPINE, 2003, 28 (04) :372-377
[10]
Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages [J].
Burkus, JK ;
Gornet, MF ;
Dickman, CA ;
Zdeblick, TA .
JOURNAL OF SPINAL DISORDERS & TECHNIQUES, 2002, 15 (05) :337-349